Advanced search
Publication Cover
Expert Review of Vaccines Volume 12, 2013 - Issue 9
Submit an article Journal homepage
4,226
Views
139
CrossRef citations to date
0
Altmetric
Reviews

The evolving history of influenza viruses and influenza vaccines

Claude HannounInstitut Pasteur, Paris, France+33 146 568 [email protected]
Pages 1085-1094 | Published online: 09 Jan 2014

References

  • Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancet, 222(5732), 66–68 (1933).
  • Smorodintseff AA, Tushinsky MD, Drobyshevskaya AI, Korovin AA, Osetroff AI. Investigation on volunteers infected with the influenza virus. Am J Med Sciences, 194(2), 159–170 (1937).
  • Kendal AP, Phillips DJ, Webster RG, Galland GG, Reimer CB. Effect of test system on the ability of monoclonal antibodies to detect antigenic drift in influenza A(H1N1) virus haemagglutinins. J. Gen. Virol., 54( Pt 2), 253–261 (1981).
  • Potter CW. Attenuated influenza virus vaccines. Rev Med Virol, 4(4), 279–292 (1994).
  • Harper SA, Fukuda K, Cox NJ, Bridges CB. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 52(RR-13), 1–8 (2003).
  • Francis T. The development of the 1943 vaccination study of the commission on influenza. Am J Epidemiol, 42(1), 1–11 (1945).
  • Burnet FM. Influenza virus on the developing egg. IV. The pathogenicity and immunizing power of egg Vvirus for ferrets and mice. Br. J. Exp. Pathol., 18(1), 37–43 (1937).
  • Francis T, Salk JE, Pearson HE, Brown PN. Protective effect of vaccination against induced influenza A. J. Clin. Invest., 24(4), 536–546 (1945).
  • Salk JE, Pearson HE, Brown PN, Francis T. Protective effect of vaccination against induced influenza B. J. Clin. Invest., 24(4), 547–553 (1945).
  • Salk JE, Menke WJ, Francis T. A clinical, epidemiological and immunological evaluation op vaccination against epidemic influenza. Am J Epidemiol, 42(1), 57–93 (1945).
  • Stanley WM. The preparation and properties of influenza virus vaccines concentrated and purified by differential contrifugation. J. Exp. Med., 81(2), 193–218 (1945).
  • Isken B, Genzel Y, Reichl U. Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants. Vaccine, 30(35), 5253–5261 (2012).
  • Osterhaus A, Fouchier R, Rimmelzwaan G. Towards universal influenza vaccines? Philos. Trans. R. Soc. Lond. B. Biol. Sci., 366(1579), 2766–2773 (2011).
  • Francis T Jr., Salk JE. A simplified procedure for the concentration and purification of influenza virus. Science, 96(2500), 499–500 (1942).
  • Stanley WM. An evaluation of methods for the concentration and purification of influenza virus. J. Exp. Med., 79(3), 255–266 (1944).
  • Panthier R, Cateigne G, Hannoun C. Isolation of influenza virus strain. Reaction of a young monkey following intra-nasal innoculation with this virus [Isolement d'une souche de virus grippal. Réaction du jeune singe à l'inoculation intra-nasale de ce virus]. C R Hebd Seances Acad Sci, 228(4), 347 (1949).
  • Mulder J, Masurel N. Pre-epidemic antibody against 1957 strain of Asiatic influenza in serum of older people living in the Netherlands. Lancet, 1(7025), 810–814 (1958).
  • Cockburn WC, Delon PJ, Ferreira W. Origin and progress of the 1968–69 Hong Kong influenza epidemic. Bull. World Health Organ., 41(3), 345–348 (1969).
  • Kendal AP, Maassab HF, Alexandrova GI, Ghendon YZ. Development of cold-adapted recombinant live, attenuated influenza A vaccines in the U.S.A. and U.S.S.R. Antiviral Res., 1(6), 339–365 (1982).
  • Saw TA, Lim W, Shortridge K et al. Isolation of avian influenza A(H5N1) viruses from humans--Hong Kong, May-December 1997. MMWR. Morb. Mortal. Wkly. Rep., 46(50), 1204–1207 (1997).
  • Strategic Advisory Group of Experts. Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations. Wkly. Epidemiol. Rec., 84(23), 220–236 (2009).
  • de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J. Med. Virol., 61(1), 94–99 (2000).
  • Gerdil C. The annual production cycle for influenza vaccine. Vaccine, 21(16), 1776–1779 (2003).
  • , W. H. O. Writing GroupAmpofo WK, Baylor N et al. Improving influenza vaccine virus selection. Report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010. Influenza Other Respi Viruses, 6(2), 142–152 (2012).
  • Smith DJ, Lapedes AS, de Jong JC et al. Mapping the antigenic and genetic evolution of influenza virus. Science, 305(5682), 371–376 (2004).
  • Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. Am J Public Health, 103(3), e43–51 (2013).
  • Barr IG, Jelley LL. The coming era of quadrivalent human influenza vaccines: who will benefit? Drugs, 72(17), 2177–2185 (2012).
  • Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine, 28 Suppl 4, D45–53 (2010).
  • Meijer A, Meerhoff TJ, Meuwissen LE, van der Velden J, Paget WJ. Epidemiological and virological assessment of influenza activity in Europe during the winter 2005–2006. Euro Surveill, 12(9), E11–12 (2007).
  • Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology, 175(1), 59–68 (1990).
  • Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother, 8(1), 81–88 (2012).
  • Beran J, Wertzova V, Honegr K et al. Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis, 9, 2 (2009).
  • Chi XS, Hu A, Bolar TV et al. Detection and characterization of new influenza B virus variants in 2002. J. Clin. Microbiol., 43(5), 2345–2349 (2005).
  • Dapat C, Saito R, Kyaw Y et al. Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007. Intervirology, 52(6), 310–320 (2009).
  • Huang QS, Lopez L, Adlam B. Influenza surveillance in New Zealand in 2005. N Z Med J, 120(1256), U2581 (2007).
  • Miller ER, Fielding JE, Grant KA, Barr IG, Papadakis G, Kelly HA. Higher than expected seasonal influenza activity in Victoria, 2007. Commun Dis Intell Q Rep, 32(1), 63–70 (2008).
  • Turner J, Clothier HJ, Kaye M. Influenza surveillance in Victoria, 2004. Commun Dis Intell Q Rep, 29(1), 71–76 (2005).
  • Chiu SS, Chan KH, Chen H et al. Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis, 49(7), 1016–1021 (2009).
  • D'Agaro P, Rossi T, Burgnich P et al. The molecular epidemiology of influenza viruses: a lesson from a highly epidemic season. J. Clin. Pathol., 61(3), 355–360 (2008).
  • Dhara R, Teates K, Brammer L et al. Update: Influenza activity--United States and worldwide, 2004–05 season. MMWR. Morb. Mortal. Wkly. Rep., 54(25), 631–634 (2005).
  • Lee BY, Bartsch SM, Willig AM. The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine, 30(52), 7443–7446 (2012).
  • Schwartz B, Hinman A, Abramson J et al. Universal influenza vaccination in the United States: are we ready? Report of a meeting. J Infect Dis, 194 Suppl 2, S147–154 (2006).
  • A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull. World Health Organ., 58(4), 585–591 (1980).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.